07:00 , Apr 29, 2013 |  BioCentury  |  Emerging Company Profile

Avilex: One-two pain punch

Avilex Pharma ApS may have found a way to block activation of the NMDA receptor pathway to treat chronic pain and ischemic stroke. Rather than directly hitting the receptor itself, the approach targets a downstream...
07:00 , Apr 22, 2013 |  BC Week In Review  |  Financial News

Avilex completes venture financing

Avilex Pharma ApS , Denmark   Business: Neurology   Date completed: 4/15/13   Type: Venture financing   Raised: Not disclosed   Investor: Novo Seeds  ...
00:11 , Apr 17, 2013 |  BC Extra  |  Financial News

Avilex debuts to develop compounds for neuropathic pain

Avilex Pharma ApS (Copenhagen, Denmark) debuted with undisclosed seed funding from Novo Seeds to develop small molecule ligands targeting discs large homolog 4 ( DLG4 ; PSD95 ) for neurology indications. Avilex's lead compounds --...